US-Listed Public Company Profile built from SEC and market records · June 2026

Axsome Therapeutics, Inc. (AXSM)

$143.51 +0.92% NASDAQ: AXSM · 15-min delayed

NEW YORK, New York
Public · NASDAQ: AXSM
925 employees
Founded 2012

Visit website Follow

$12.4BMarket cap

$638.5MRevenue · FY2025

-$183.2MNet income

925Employees

AXSMNASDAQ

2015IPO

About Axsome Therapeutics, Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Founded: 2012
Type: Public · NASDAQ: AXSM
Employees: 925
IPO date: Nov 19, 2015
Headquarters: ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK, New York 10007
Phone: (212) 332-3241
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 549300EXGR0XLRJEIB95

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: AXSM Nasdaq
SEC CIK: 1579428
LEI: 549300EXGR0XLRJEIB95
EIN: 454241907
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Axsome Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/axsome-therapeutics-inc/"><img src="https://americancompanies.com/badge/axsome-therapeutics-inc.svg" alt="Axsome Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Axsome Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $638.5M
Net income: -$183.2M
Total assets: $689.8M
Market cap: $12.4B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AXSM

$143.51 +0.92%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$116.01 $255.17

52-week range

Market cap: $12.4B
Shares outstanding: 86.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Nov 19, 2015

Axsome Therapeutics, Inc. (AXSM) Stock Price

Reported a net loss of $183.2M in FY2025.
Trading 44% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

Jazz Pharmaceuticals plcJAZZ

No reviews yet. Be the first to review Axsome Therapeutics, Inc..

Write a review

Newsroom

News about Axsome Therapeutics, Inc.

AC Original Inside America's Pharmaceutical Industry: Who's Building It A look at eight verified American pharmaceutical companies, from Illinois biotech giants to California gene-therapy inn… Jul 10, 2026

AC Original Inside America's Pharmaceutical Industry: The Companies Behind the Medicine Cabinet A look at eight verified American pharmaceutical companies, where they're based, and why domestic drugmakers matter to … Jul 8, 2026

AC Original Pharmaceuticals in America: A Guide to Verified U.S. Drug Makers An overview of America's pharmaceutical industry and eight independently verified companies, from Illinois giants to Ca… Jul 7, 2026

AC Original Pharmaceuticals in America: The Companies Behind the Nation's Medicine Cabinet A look at the American pharmaceutical sector and eight independently verified companies, from Illinois giants to coasta… Jul 7, 2026

Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp Volatility The Motley Fool · 2026-10-28 · positive Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks Investment Research · 2026-10-27 · negative Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should Know Zacks Investment Research · 2026-10-26 · negative 2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks) The Motley Fool · 2026-10-23 · positive Alzheimer's Disease Clinical Trial and Competitive Landscape Enters a New Phase as 200+ Companies Advance Clinical Programs | DelveInsight GlobeNewswire Inc. · 2026-10-22 · positive Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3? Zacks Investment Research · 2026-10-21 · positive

News & sentiment via Polygon.io

FAQ

Axsome Therapeutics, Inc.: frequently asked questions

Is Axsome Therapeutics, Inc. an American company?

Yes — Axsome Therapeutics, Inc. is an American company headquartered in New York, New York. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Axsome Therapeutics, Inc. headquartered?

Axsome Therapeutics, Inc. is headquartered in New York, New York, United States.

Is Axsome Therapeutics, Inc. publicly traded?

Yes — Axsome Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol AXSM on the NASDAQ.

What does Axsome Therapeutics, Inc. do?

Axsome Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

When was Axsome Therapeutics, Inc. founded?

Axsome Therapeutics, Inc. was founded in 2012.

Explore